Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor

Ann Hematol. 2015 Jul;94(7):1237-9. doi: 10.1007/s00277-015-2352-9. Epub 2015 Mar 21.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow Neoplasms / complications
  • Bone Marrow Neoplasms / diagnosis
  • Bone Marrow Neoplasms / drug therapy*
  • Female
  • Humans
  • Janus Kinases / antagonists & inhibitors*
  • Nitriles
  • Polycythemia Vera / complications
  • Polycythemia Vera / diagnosis
  • Polycythemia Vera / drug therapy*
  • Pyrazoles / therapeutic use*
  • Pyrimidines
  • Treatment Outcome
  • Young Adult
  • beta-Thalassemia / complications
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / drug therapy*
  • delta-Thalassemia / complications
  • delta-Thalassemia / diagnosis
  • delta-Thalassemia / drug therapy*

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Janus Kinases

Supplementary concepts

  • Delta-Beta Thalassemia